2001-261612 is referenced by 11 patents.

PROBLEM TO BE SOLVED: To obtain a prophylactic or therapeutic agent for various kinds of diseases, e.g. diabetes mellitus, hyperlipidemia, arteriosclerosis, etc., by activating peroxisome proliferator-activated receptor(PPAR)-α or -γ which is a nuclear transcription factor and relates to the diseases.SOLUTION: A medicine containing a benzothiophene derivative represented by the general formula (1) as an active ingredient is used. Since the compound powerfully operates the PPAR-α or -γ which is the nuclear transcription factor and has low toxicity, the compound is expected in effectiveness as the prophylactic or therapeutic agent for the various kinds of diseases relating to the PPAR-α or -γ.

Catecholpropionic acid derivative and nuclear receptor agonist containing the same as active ingredient
Application Number
Publication Number
Application Date
March 22, 2000
Publication Date
September 26, 2001
Morikawa Maki
Uda Hideyuki
Kobayashi Kenji
Takebayashi Nozomi
Asada Noriaki
Nakao Toshifumi
Maruyama Kyoko
Fukazawa Nobuyuki
Tsunoda Hidetoshi
Mitsui Chemicals
C07D 333/70
C07D 263/58
C07D 263/32
C07C 255/54
C07C 235/06
C07C 233/69
C07C 217/18
C07C 69/734
A61P 37/08
A61P 37/00
A61P 35/00
A61P 31/18
A61P 31/06
A61P 29/00
A61P 11/06
A61P 11/00
A61P 09/10
A61P 07/00
A61P 03/10
A61P 03/06
A61P 01/16
A61P 01/04
A61P 01/00
A61K 31/423
A61K 31/381
A61K 31/275
A61K 31/216
A61K 31/195
A61K 31/192
C07C 59/13